摘要
目的:大肠癌(CRC)在年轻人群的发病率程上升趋势;但这些年轻患者的特征和预后还不完全明确。本回顾性研究目的是分析中国30岁以下结直肠癌患者的临床病理特征。 方法:我们从上海长征医院1995年1月至2013年12月期间患原发性大肠癌的5830名病人中,选取了年龄在13-30岁的83名直肠癌患者(平均年龄26.1岁,其中33名为男性、50名女性)的临床病理特征进行回顾分析。 结果:从出现症状到确诊时间为3天到24个月(平均4.6个月)。诊断时最常见的症状是便血,占所有患者的66.3%。60.2%的患者在直肠出现肿瘤,72.8%出现肿瘤晚期疾病(TNM 三期或四期)。相对于女性患者,更多男性患者出现在M1期。大肠癌转移患者在诊断是抱怨疲劳,这点与未转移患者比较具有显著性差异(31.0% 对5.8%, p = 0.002), 但两组排便习惯改变差异性较小(38%对65.4%,P = 0.017)。此外,转移患者组合未转移患者组的肿瘤组织学分布有统计学意义差异(P = 0.021)。 结论:与老年大肠癌患者相比,年轻的大肠癌患者(<30岁)有更高频次的粘液腺癌,更恶性疾病和差的预后。年轻大肠癌患者临床病理特征的识别将有助于该类特殊患者组的临床诊断和治疗。
关键词: 中国人群,临床病理特征,大肠癌,年轻人
图形摘要
Current Cancer Drug Targets
Title:Clinicopathological Characteristics of Chinese Colorectal Cancer Patients under 30 Years of Age: Implication in Diagnosis and Therapy
Volume: 15 Issue: 1
Author(s): Changpeng Zhu, Meng Ji, Weiping Dai, Changhong Ye, Zhiqian Hu, Jian Shi, Xin Zeng and Yong Lin
Affiliation:
关键词: 中国人群,临床病理特征,大肠癌,年轻人
摘要: Objectives: The incidence of colorectal cancer (CRC) is increasing in younger populations; the characteristics and prognosis of those younger patients are not fully understood. The aim of this retrospective study was to analyze the clinicopathological features of Chinese CRC patients under 30 years of age.
Methods: We reviewed the clinical and pathological features of 83 CRC patients (33 males and 50 females) aged 13-30 years (mean, 26.1 years) selected from consecutive 5,830 patients with primary CRC referred to Shanghai Changzheng Hospital between January 1995 and December 2013.
Results: The duration from the onset of symptoms to diagnosis ranged from 3 days to 24.0 months (average 4.6 months). The most common symptom at the time of diagnosis was bloody stool, occurring in 66.3% of the patients. 60.2% patients had tumors located in the rectum and 72.8% of them presented advanced diseases (TNM stage III or IV). More male patients presented as M1 stage than the female patients. Patients with CRC metastasis complained of more fatigue at the time of diagnosis than their counterparts without metastasis (31.0% vs. 5.8%, p = 0.002), but had less pronounced bowel habit change (38.0% vs. 65.4%, p = 0.017). Additionally, there were differences in histologic distributions of the tumors between patients with and without metastasis (p = 0.021).
Conclusions: Compared with older CRC patients, younger CRC patients (<30 yr) have a higher frequency of mucinous adenocarcinomas, more aggressive diseases and poorer prognosis. Identification of clinicopathological characteristics in younger CRC patients would help diagnose and treat the disease in this unique group of CRC patients in the clinic.
Export Options
About this article
Cite this article as:
Changpeng Zhu, Meng Ji, Weiping Dai, Changhong Ye, Zhiqian Hu, Jian Shi, Xin Zeng and Yong Lin , Clinicopathological Characteristics of Chinese Colorectal Cancer Patients under 30 Years of Age: Implication in Diagnosis and Therapy, Current Cancer Drug Targets 2015; 15 (1) . https://dx.doi.org/10.2174/1568009615666150101115800
DOI https://dx.doi.org/10.2174/1568009615666150101115800 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomedical Data Integration in Computational Drug Design and Bioinformatics
Current Computer-Aided Drug Design MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer
Current Cancer Drug Targets Identification of the Altered Proteins Related to Colon Carcinogenesis by iTRAQ-based Quantitative Proteomic Analysis
Current Proteomics Cellular Senescence and Anti-Cancer Therapy
Current Drug Targets Optimization of Time Controlled 6-mercaptopurine Delivery for Site- Specific Targeting to Colon Diseases
Current Drug Delivery Chronopharmaceuticals: Hype or Future of Pharmaceutics
Current Pharmaceutical Design Compartmentalized Platforms for Neuro-Pharmacological Research
Current Neuropharmacology Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Approaches Targeting KV10.1 Open a Novel Window for Cancer Diagnosis and Therapy
Current Medicinal Chemistry Serenoa Repens, Lycopene and Selenium: A Triple Therapeutic Approach to Manage Benign Prostatic Hyperplasia
Current Medicinal Chemistry The Role of Bacterial Lipopolysaccharides as Immune Modulator in Vaccine and Drug Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Similar Mechanisms Regulated by γ-Secretase are Involved in Both Directions of the Bi-Directional Notch-Delta Signaling Pathway as well as Play a Potential Role in Signaling Events Involving Type 1 Transmembrane Proteins
Current Stem Cell Research & Therapy MicroRNA-21 as a Novel Therapeutic Target
Current Cancer Therapy Reviews Generalized String Pseudo-Folding Lattices in Bioinformatics: State-of-Art Review, New Model for Enzyme Sub-Classes, and Study of ESTs on Trichinella spiralis
Current Bioinformatics Genetic Alterations in Differentiated Thyroid Cancers
Endocrine, Metabolic & Immune Disorders - Drug Targets Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases
Current Drug Targets Tumor Specific Imaging Using Tc-99m and Ga-68 Labeled Radiopharmaceuticals
Current Medical Imaging Optimizing Anti-EGFR Strategies in Cancer Treatment
Current Cancer Therapy Reviews Prevention of Non-communicable Diseases by Balanced Nutrition: Population- specific Effective Public Health Approaches in Developing Countries
Current Diabetes Reviews Cancer Chemoprevention by Dietary Phytochemicals: Promises and Pitfalls
Current Pharmaceutical Biotechnology